202 related articles for article (PubMed ID: 17330501)
21. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
22. Effects of alendronate and alfacalcidol on the femoral bone mass and bone strength in orchidectomized rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Xu E; Yeh JK
Chin J Physiol; 2008 Dec; 51(6):331-7. PubMed ID: 19280876
[TBL] [Abstract][Full Text] [Related]
23. Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats.
Samnegård E; Iwaniec UT; Cullen DM; Kimmel DB; Recker RR
Bone; 2001 Mar; 28(3):251-60. PubMed ID: 11248654
[TBL] [Abstract][Full Text] [Related]
24. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis.
Shiraishi A; Higashi S; Masaki T; Saito M; Ito M; Ikeda S; Nakamura T
Calcif Tissue Int; 2002 Jul; 71(1):69-79. PubMed ID: 12073154
[TBL] [Abstract][Full Text] [Related]
25. Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats.
Ejersted C; Oxlund H; Eriksen EF; Andreassen TT
Bone; 1998 Jul; 23(1):43-52. PubMed ID: 9662129
[TBL] [Abstract][Full Text] [Related]
26. [Effects of alfacalcidol on osteoporosis in ovariectomized rats].
Xia W; Meng X; Xing X
Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):702-5. PubMed ID: 11798840
[TBL] [Abstract][Full Text] [Related]
27. Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats.
Fuchs RK; Phipps RJ; Burr DB
J Bone Miner Res; 2008 Oct; 23(10):1689-97. PubMed ID: 18466070
[TBL] [Abstract][Full Text] [Related]
28. Alfacalcidol treatment increases bone mass from anticatabolic and anabolic effects on cancellous and cortical bone in intact female rats.
Liu XQ; Chen HY; Tian XY; Setterberg RB; Li M; Jee WS
J Bone Miner Metab; 2008; 26(5):425-35. PubMed ID: 18758900
[TBL] [Abstract][Full Text] [Related]
29. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
[TBL] [Abstract][Full Text] [Related]
30. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model.
Saito M; Shiraishi A; Ito M; Sakai S; Hayakawa N; Mihara M; Marumo K
Bone; 2010 Apr; 46(4):1170-9. PubMed ID: 20026440
[TBL] [Abstract][Full Text] [Related]
31. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats.
Chen HK; Jee WS; Ma YF; Pan Z; McOsker JE; Li XJ
Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930
[TBL] [Abstract][Full Text] [Related]
32. Risedronate improves bone architecture and strength faster than alendronate in ovariectomized rats on a low-calcium diet.
Yano T; Yamada M; Konda T; Shiozaki M; Inoue D
J Bone Miner Metab; 2014 Nov; 32(6):653-9. PubMed ID: 24357144
[TBL] [Abstract][Full Text] [Related]
33. Alfacalcidol-stimulated focal bone formation on the cancellous surface and increased bone formation on the periosteal surface of the lumbar vertebrae of adult female rats.
Chen H; Tian X; Liu X; Setterberg RB; Li M; Jee WS
Calcif Tissue Int; 2008 Feb; 82(2):127-36. PubMed ID: 18175034
[TBL] [Abstract][Full Text] [Related]
34. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
[TBL] [Abstract][Full Text] [Related]
35. Additive effect of treadmill exercise and 17 beta-estradiol replacement on prevention of tibial bone loss in adult ovariectomized rat.
Yeh JK; Liu CC; Aloia JF
J Bone Miner Res; 1993 Jun; 8(6):677-83. PubMed ID: 8328309
[TBL] [Abstract][Full Text] [Related]
36. Effect of vitamin K2 on cortical and cancellous bone mass and hepatic lipids in rats with combined methionine-choline deficiency.
Iwamoto J; Seki A; Sato Y; Matsumoto H; Takeda T; Yeh JK
Bone; 2011 May; 48(5):1015-21. PubMed ID: 21352961
[TBL] [Abstract][Full Text] [Related]
37. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.
Iwata K; Li J; Follet H; Phipps RJ; Burr DB
Bone; 2006 Nov; 39(5):1053-1058. PubMed ID: 16807159
[TBL] [Abstract][Full Text] [Related]
38. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.
Dalle Carbonare L; Bertoldo F; Valenti MT; Zordan S; Sella S; Fassina A; Turco G; Realdi G; Lo Cascio V; Giannini S
J Endocrinol Invest; 2007 Oct; 30(9):739-46. PubMed ID: 17993765
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats.
Shen Y; Li M; Wronski TJ
Calcif Tissue Int; 1997 May; 60(5):457-61. PubMed ID: 9115164
[TBL] [Abstract][Full Text] [Related]
40. Additive effects of combined treatment with etidronate and alfacalcidol on bone mass and mechanical properties in ovariectomized rats.
Nishikawa T; Ogawa S; Kogita K; Manabe N; Katsumata T; Nakamura K; Kawaguchi H
Bone; 2000 Nov; 27(5):647-54. PubMed ID: 11062351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
